| Literature DB >> 32475844 |
Eunhye Oh1, Sug-Joon Ahn2, Liselotte Sonnesen1.
Abstract
OBJECTIVE: To compare short- and long-term dentoalveolar, skeletal, and rotational changes evaluated by Björk's structural method of superimposition between children with Class II malocclusion treated by functional appliances and untreated matched controls.Entities:
Keywords: Class II malocclusion; Functional appliance; Growth evaluation; Superimposition
Year: 2020 PMID: 32475844 PMCID: PMC7270938 DOI: 10.4041/kjod.2020.50.3.170
Source DB: PubMed Journal: Korean J Orthod Impact factor: 1.372
Figure 1Functional appliances used in the present study. A and B, Z-activator (Teuscher activator with a high-pull headgear)[10]. C, E-activator (modified Andresen activator, also known as an Ergenzinger activator).[11]
Figure 2Cephalometric landmarks used for measurements.[14]
n, Nasion; s, sella; cd, condylion; ba, basion; ar, articulare; gn, gnathion; pg, pogonion; sm, supramentale; isi, incisal superior incisor; iii, incisal inferior incisor; ss, subspinale; sp, spinale; MBLar, mandibular base line; Rlar, ramus line; ILi, incisal line inferior; ILs, incisal line superior; ML, mandibular line; NL, nasal line.
Figure 3Illustration of superimposition on the stable structures in the anterior cranial base between two stages.[9]
NSLRef, Nasion-sella line at before treatment (T1) transferred to the following lateral cephalogram as a reference line when the two sets are superimposed on the stable structures in the anterior cranial base; MaxillaRef, a reference line drawn in the maxilla when the two sets are superimposed on the stable structures in the maxilla; MandibleRef, a reference line drawn in the mandible when the two sets are superimposed on the stable structures in the mandible.
Figure 4Illustration of superimposition on the stable structures in the maxilla between two stages.[9]
MaxillaRef, Maxillary reference line; ILs1, incisal line superior stage 1; ILs2, incisal line superior stage 2; isi1, incisal superior stage 1; isi2, incisal superior stage 2.
Figure 5Illustration of superimposition on the stable structures in the mandible between two stages.[9]
cd, Condylion; cdRef, condylion at baseline (T1); MandibleRef, mandibular reference line; ILi1, incisal line inferior stage 1; ILi2, incisal line inferior stage 2; iii1, incisal inferior stage 1; iii2, incisal inferior stage 2.
Comparison of baseline craniofacial characteristics (T1) between children treated with Class II functional appliances and untreated children
| Variable | Z-activator (15 girls, 19 boys) | E-activator (16 girls, 12 boys) | Control (8 girls, 9 boys) | ||
|---|---|---|---|---|---|
| Z vs. C | E vs. C | ||||
| CVM methods | NS | NS | |||
| CS1 | 5 (14.7) | 7 (25.0) | 1 (5.9) | ||
| CS2 | 13 (38.2) | 11 (39.3) | 7 (41.2) | ||
| CS3 | 10 (29.4) | 7 (25.0) | 9 (52.9) | ||
| CS4 | 6 (17.6) | 3 (10.7) | 0 (0) | ||
| Treatment timing | NS | NS | |||
| Early (pre-peak) | 17 (50.0) | 17 (60.7) | 8 (47.1) | ||
| Late (on-peak) | 17 (50.0) | 11 (39.3) | 9 (52.9) | ||
| Upper spine morphology | |||||
| Fusion | 3 (8.8) | 7 (25.0) | 2 (11.8) | NS | NS |
| PAD | 8 (23.5) | 8 (28.6) | 3 (17.6) | NS | NS |
| Age (yr) | 11.82 ± 1.48 | 11.17 ± 1.20 | 11.76 ± 1.50 | NS | NS |
| Atlas dimension (mm) | |||||
| Dorsal arch height | 8.49 ± 1.59 | 7.70 ± 2.03 | 8.09 ± 1.59 | NS | NS |
| PNAH | 4.02 ± 0.68 | 3.90 ± 0.92 | 4.19 ± 0.93 | NS | NS |
| A-P dimension | 45.11 ± 2.91 | 44.19 ± 3.28 | 43.47 ± 3.26 | NS | NS |
| Cranial base angle (°) | |||||
| n-s-ba | 134.24 ± 4.96 | 131.74 ± 5.25 | 130.57 ± 4.20 | < 0.05 | NS |
| Sagittal dimensions (°) | |||||
| ss-n-pg | 6.07 ± 1.67 | 5.14 ± 1.78 | 4.14 ± 1.94 | < 0.01 | NS |
| s-n-ss | 80.33 ± 2.89 | 80.81 ± 3.17 | 80.95 ± 3.01 | NS | NS |
| s-n-pg | 74.27 ± 2.66 | 75.69 ± 3.79 | 76.82 ± 3.42 | < 0.05 | NS |
| Vertical dimensions (°) | |||||
| NL/ML | 27.88 ± 4.04 | 24.37 ± 5.09 | 27.57 ± 7.73 | NS | < 0.05 |
| NSL/NL | 8.73 ± 3.17 | 8.48 ± 3.78 | 6.74 ± 2.11 | NS | NS |
| NSL/ML | 36.61 ± 4.25 | 32.85 ± 6.77 | 34.31 ± 8.07 | NS | NS |
| Mandibular form (°) | |||||
| ML/Rlar | 121.34 ± 5.54 | 120.33 ± 8.15 | 124.47 ± 6.99 | NS | < 0.05 |
| ML/MBLar | 19.26 ± 2.83 | 19.95 ± 2.96 | 19.17 ± 3.21 | NS | NS |
| Dental | |||||
| Overjet (mm) | 8.64 ± 2.11 | 8.45 ± 2.29 | 7.25 ± 2.29 | < 0.001 | < 0.01 |
| Overbite (mm) | 2.91 ± 1.88 | 4.04 ± 1.68 | 1.41 ± 3.35 | NS | < 0.01 |
| ILs to NL (°) | 117.26 ± 6.03 | 117.41 ± 6.80 | 113.49 ± 5.77 | NS | NS |
| ILi to ML (°) | 94.78 ± 6.42 | 98.69 ± 6.67 | 94.78 ± 5.89 | NS | NS |
| Lower anterior facial height (sp-gn, mm) | 65.52 ± 3.57 | 60.02 ± 4.67 | 62.28 ± 7.69 | NS | < 0.05 |
Values are presented as number (%) or mean ± standard deviation.
Chi-square test for evaluation of CVM and upper spine morphology.
Multiple linear regression analysis for craniofacial morphology, adjusted for age, sex, and ethnicity.
Z vs. C, Significant difference between Z-activator and control; E vs. C, significant difference between E-activator and control; T1, before treatment; CVM, cervical vertebral maturation; CS1, cervical stage 1; CS2, cervical stage 2; CS3, cervical stage 3; CS4, cervical stage 4; PAD, posterior arch deficiency; PNAH, posterior neural arch height; A-P, anteroposterior; NS, not significant.
p < 0.05, **p < 0.01, ***p < 0.001.
See Figures 2 and 3 for definitions of the other landmarks.
Comparison of true craniofacial changes and jaw rotations after Class II functional appliance treatment (T1–T2) with those in the absence of treatment (control group) (superimposition on stable structures)
| Variable | Z-activator (n = 34) | E-activator (n = 28) | Control (n = 17) | ||
|---|---|---|---|---|---|
| Z vs. C | E vs. C | ||||
| Treatment duration (yr) | 1.55 ± 0.67 | 1.79 ± 1.18 | 1.46 ± 0.51 | NS | NS |
| Age at T2 (yr) | 13.36 ± 1.39 | 12.89 ± 1.45 | 13.24 ± 1.69 | NS | NS |
| Cranial base changes (°) | |||||
| n-s-ba | −1.05 ± 1.84 | −0.60 ± 2.46 | 0.38 ± 1.61 | < 0.001 | < 0.05 |
| Sagittal changes (°) | |||||
| ss-n-pg | −2.27 ± 1.28 | −1.78 ± 1.30 | −0.68 ± 0.91 | < 0.001 | < 0.001 |
| s-n-ss | −1.25 ± 1.52 | −0.67 ± 1.54 | 0.17 ± 0.81 | < 0.001 | < 0.05 |
| s-n-pg | 1.02 ± 1.31 | 1.10 ± 1.56 | 0.84 ± 0.87 | NS | NS |
| Vertical changes (°) | |||||
| NL/ML | −1.59 ± 1.72 | −1.10 ± 1.78 | −0.94 ± 2.47 | NS | NS |
| NSL/NL | 0.82 ± 1.36 | 1.43 ± 1.97 | 0.94 ± 1.85 | NS | NS |
| NSL/ML | −0.79 ± 1.65 | 0.34 ± 2.11 | −0.84 ± 1.56 | NS | NS |
| Jaw rotations (°) | |||||
| NSL/MaxillaRef | 0.09 ± 0.75 | 0.44 ± 1.53 | −0.43 ± 1.01 | NS | < 0.01 |
| NSL/MandibleRef | −1.30 ± 1.94 | −1.02 ± 2.42 | −1.67 ± 2.20 | NS | NS |
| Condylar growth (mm) | |||||
| cd-cdRef | 6.52 ± 2.71 | 8.62 ± 3.47 | 4.41 ± 2.12 | < 0.001 | < 0.001 |
| ar-arRef | 6.52 ± 2.71 | 7.44 ± 2.86 | 4.41 ± 2.20 | < 0.01 | < 0.001 |
| Mandibular form changes (°) | |||||
| ML/Rlar | 0.21 ± 2.20 | 0.84 ± 2.76 | −0.63 ± 2.45 | NS | NS |
| ML/MBLar | 0.39 ± 1.01 | −0.12 ± 1.38 | 0.24 ± 1.42 | NS | NS |
| Upper teeth to MaxillaRef | |||||
| isi horizontal (mm) | −2.54 ± 2.20 | −1.75 ± 1.83 | 0.96 ± 0.62 | < 0.001 | < 0.001 |
| isi vertical (mm) | 1.95 ± 1.89 | 2.69 ± 2.16 | 1.41 ± 0.88 | NS | < 0.05 |
| ILs inclination (°) | −5.01 ± 5.07 | −7.09 ± 5.48 | 1.89 ± 2.86 | < 0.001 | < 0.001 |
| Lower teeth to MandibleRef | |||||
| iii horizontal (mm) | 0.53 ± 1.59 | 1.54 ± 1.91 | 0.29 ± 1.15 | NS | < 0.01 |
| iii vertical (mm) | 1.66 ± 1.30 | 0.26 ± 1.60 | 0.87 ± 1.45 | < 0.05 | NS |
| ILi inclination (°) | 0.61 ± 4.76 | 4.47 ± 6.96 | 0.21 ± 3.14 | NS | < 0.001 |
| Dental relationship (mm) | |||||
| Overjet | −4.96 ± 2.20 | −5.36 ± 2.43 | 0.32 ± 1.01 | < 0.001 | < 0.001 |
| Overbite | −0.65 ± 1.60 | −2.03 ± 2.02 | −0.11 ± 1.67 | NS | < 0.01 |
| Lower anterior facial height (sp-gn, mm) | 3.22 ± 1.84 | 4.05 ± 2.08 | 1.83 ± 1.65 | < 0.05 | < 0.001 |
Values are presented as mean ± standard deviation.
Multiple linear regression analysis, adjusted for age, sex, treatment timing, treatment duration, and ethnicity.
Z vs. C, Significant difference between Z-activator and control; E vs. C, significant difference between E-activator and control; T1, before treatment; T2, after functional appliance treatment; ar-arRef, articulare-articulare at T1; NS, not significant.
p < 0.05, **p < 0.01, ***p < 0.001.
See Figures 2–5 definitions of the other landmarks.
Comparison of true craniofacial changes and jaw rotations after the retention period following Class II functional appliance treatment (T1–T3) with those in the absence of treatment (control group) (superimposition on stable structures)
| Variable | Z-activator (n = 34) | E-activator (n = 28) | Control (n = 17) | ||
|---|---|---|---|---|---|
| Z vs. C | E vs. C | ||||
| Treatment duration (yr) | 3.58 ± 1.25 | 3.75 ± 1.75 | 3.41 ± 0.97 | NS | NS |
| Age (yr) | 15.36 ± 1.49 | 14.84 ± 1.90 | 15.56 ± 1.74 | NS | NS |
| Cranial base changes (°) | |||||
| n-s-ba | −2.41 ± 2.35 | −1.77 ± 2.76 | −0.34 ± 2.23 | < 0.01 | NS |
| Sagittal changes (°) | |||||
| ss-n-pg | −2.19 ± 1.53 | −2.17 ± 1.44 | −0.92 ± 1.33 | < 0.001 | < 0.01 |
| s-n-ss | −0.27 ± 1.80 | −0.15 ± 1.84 | 0.56 ± 1.13 | < 0.01 | NS |
| s-n-pg | 1.92 ± 1.78 | 2.00 ± 1.76 | 1.46 ± 1.76 | NS | NS |
| Vertical changes (°) | |||||
| NL/ML | −1.23 ± 2.60 | −1.45 ± 2.19 | −1.72 ± 2.84 | NS | NS |
| NSL/NL | 0.04 ± 2.04 | 0.96 ± 1.82 | 0.04 ± 2.09 | NS | NS |
| NSL/ML | −1.10 ± 2.53 | −0.41 ± 2.01 | −1.69 ± 2.31 | NS | NS |
| Jaw rotations (°) | |||||
| NSL/MaxillaRef | −0.86 ± 1.03 | −0.32 ± 1.66 | −0.79 ± 1.28 | NS | NS |
| NSL/MandibleRef | −2.34 ± 3.41 | −2.49 ± 2.68 | −3.19 ± 3.08 | NS | NS |
| Condylar growth (mm) | |||||
| cd-cdRef | 11.54 ± 5.08 | 12.74 ± 5.16 | 9.65 ± 4.24 | NS | NS |
| ar-arRef | 9.78 ± 5.21 | 10.35 ± 4.90 | 8.14 ± 3.70 | NS | NS |
| Mandibular form changes (°) | |||||
| ML/Rlar | −1.69 ± 2.51 | −1.42 ± 2.94 | −2.64 ± 2.16 | NS | NS |
| ML/MBLar | 1.22 ± 1.61 | 0.77 ± 1.29 | 0.85 ± 1.39 | NS | NS |
| Upper teeth to MaxillaRef | |||||
| isi horizontal (mm) | −2.28 ± 3.39 | −1.53 ± 2.87 | 1.34 ± 0.89 | < 0.001 | < 0.001 |
| isi vertical (mm) | 3.92 ± 1.94 | 4.39 ± 2.45 | 2.85 ± 1.54 | < 0.001 | NS |
| ILs inclination (°) | −5.18 ± 7.09 | −6.61 ± 8.22 | 2.21 ± 2.37 | < 0.001 | < 0.001 |
| Lower teeth to MandibleRef | |||||
| iii horizontal (mm) | 1.24 ± 2.36 | 1.75 ± 2.20 | 0.43 ± 1.21 | NS | < 0.01 |
| iii vertical (mm) | 1.96 ± 2.21 | 1.11 ± 1.87 | 2.00 ± 1.94 | NS | < 0.01 |
| ILi inclination (°) | 4.14 ± 7.69 | 4.25 ± 5.81 | 0.83 ± 3.47 | NS | < 0.01 |
| Dental relationship (mm) | |||||
| Overjet | −5.84 ± 2.55 | −5.54 ± 2.57 | 0.48 ± 1.25 | < 0.001 | < 0.001 |
| Overbite | −1.50 ± 1.38 | −1.96 ± 1.49 | 0.15 ± 1.17 | < 0.05 | < 0.001 |
| Lower anterior facial height (sp-gn, mm) | 6.02 ± 2.31 | 6.51 ± 3.17 | 3.82 ± 2.62 | < 0.05 | < 0.05 |
Values are presented as mean ± standard deviation.
Multiple linear regression analysis, adjusted for age, sex, treatment timing, treatment duration, and ethnicity.
Z vs. C, Significant difference between Z-activator and control; E vs. C, significant difference between E-activator and control; T1, before treatment; T3, after retention; ar-arRef, articulare-articulare at T1; NS, not significant.
p < 0.05, **p < 0.01, ***p < 0.001.
See Figures 2–5 definitions of the other landmarks.